Tomczak, P. “Cabozantinib in Monotherapy and Combination Therapy for First-Line Renal Cell Carcinoma: Patient Profiles”. OncoReview, Vol. 15, no. 1(57), June 2025, pp. 12-17, doi:10.24292/01.OR.151220925.